Journal article
Antimicrobial Resistance of Campylobacter spp. Causing Human Infection in Australia: An International Comparison
RL Wallace, D Bulach, A McLure, L Varrone, AV Jennison, M Valcanis, JJ Smith, BG Polkinghorne, K Glass, MD Kirk
Microbial Drug Resistance | MARY ANN LIEBERT, INC | Published : 2021
Abstract
The study investigates the prevalence of antimicrobial resistance in Campylobacter jejuni and Campylobacter coli in gastroenteritis patients in the eight most populous regions in Australia and compares the prevalence of antimicrobial resistance in Europe and North America. A total of 164 Campylobacter isolates were collected from patients with campylobacteriosis and tested for susceptibility to six antimicrobials using ETEST® strips and compared with reports from Europe and the United States. Genomes were sequenced on Illumina NextSeq to identify genetic determinants of resistance. Phenotypically, 1.8%, 14.0%, 14.6%, and 20.1% of isolates were resistant to erythromycin (ERY), ampicillin, tet..
View full abstractGrants
Awarded by Hunter New England Local Health District
Funding Acknowledgements
This work was funded by a National Health and Medical Research Council grant (NHMRC GNT1116294), Agri-Futures, Australian Government Department of Health, Food Standards Australia New Zealand, New South Wales Food Authority and Queensland Health. The National Health & Medical Research Council provided research fellowship funding for M.D. K. (APP1145997).